Doctor’s Guide -- ROCKVILLE, Md -- September 15, 2010 -- The US Food and Drug Administration (FDA) is notifying healthcare professionals of updated dosing recommendations for valganciclovir (Valcyte) oral tablets and solution used by children and adolescents receiving a kidney or heart transplant.
